Search | IOVS | ARVO Journals

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Systematic Review and Meta-Analysis of Massive Suprachoroidal Hemorrhage

Tianyu Liu; Ayman G. Elnahry; Zujaja Tauqeer; Yinxi Yu; Gui-Shuang Ying; Benjamin J Kim

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3398 – F0298. doi:

ARVO Annual Meeting Abstract July 2019

Clinical Utility of beta-D-glucan Testing for Detecting Fungal Chorioretinitis and/or Endophthalmitis

Michael Ammar; Robert Carroll; Anton M Kolomeyer; Gui-Shuang Ying; Gideon Whitehead; Alexander J Brucker; Benjamin J Kim

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):832. doi:

ARVO Annual Meeting Abstract July 2019

Supplementation with alpha lipoic acid to treat geographic atrophy from AMD

Benjamin J Kim

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4216. doi:

ARVO Annual Meeting Abstract July 2019

Outer Retina Thinning Distinguishes Frontotemporal Degeneration from Alzheimer’s Disease

Benjamin J Kim; Murray Grossman; Adrienne Saludades; Delu Song; Joshua L Dunaief; Brendan McGeehan; Gui-Shuang Ying; Tomas S Aleman; David Irwin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2296. doi:

ARVO Annual Meeting Abstract July 2018

Long term Follow up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Benjamin J Kim; Wei Pan; Juan E Grunwald; Gui-Shuang Ying; Cynthia A Toth; Glenn J Jaffe; Daniel F Martin; Maureen G. Maguire

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3252. doi:

ARVO Annual Meeting Abstract June 2017

Frequent subclinical macular changes in melanoma patients treated with combined BRAF/MEK inhibition and high dose hydroxychloroquine does not require dosing modification or discontinuation: preliminary results from a multi-institutional phase I/II clinical treatment trial for advanced metastatic BRAF mutant melanoma

Leona Serrano; Harpal Sandhu; Elaine Zhou; Delu Song; Tara Gangadhar; Lynn Schuchter; Sheryl Mitnick; Janice Mehnert; Ann Silk; Leonel Hernandez Aya; Alexander Huang; Gerald Linette; Ravi K Amaravadi; Benjamin J Kim; Tomas S Aleman

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):255. doi:

ARVO Annual Meeting Abstract June 2017

Spectral Domain Optical Coherence Tomography Identifies Outer Retina Thinning in Frontotemporal Lobar Degeneration

Benjamin J Kim; Delu Song; David J. Irwin; Ebenezer Daniel; Jennifer D. Leveque; Aaishah R. Raquib; Wei Pan; Gui-Shuang Ying; Tomas S Aleman; Joshua L. Dunaief; Murray Grossman

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5137. doi:

ARVO Annual Meeting Abstract September 2016

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Juan E Grunwald; Benjamin J Kim; Maureen G Maguire; James A Shaffer; Glenn J Jaffe; Cynthia A Toth; Daniel F Martin; Frederick L Ferris; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2653. doi:

ARVO Annual Meeting Abstract September 2016

Longitudinal Imaging of Cone Inner and Outer Segment Mosaics in Central Serous Chorioretinopathy

Benjamin J Kim; Grace K. Han; Alexander J Brucker; Alfredo Dubra; Jessica Ijams Wolfing Morgan

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5106. doi:

ARVO Annual Meeting Abstract April 2014

Sporadic Visual Acuity Loss in the Comparison of AMD Treatments Trials (CATT)

Benjamin J Kim; Gui-Shuang Ying; Jiayan Huang; Nicole E Levy; Maureen G Maguire; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4962. doi:

Advertisement